Stock Market News

Evonik outlook revised to positive by Moody's, Baa2 rating affirmed

May 14, 2025 - 16:52
 0
Evonik outlook revised to positive by Moody's, Baa2 rating affirmed
Read More

Tags:

Previous Article

Antalpha starts trading on Nasdaq at $15.01 after $12.80 IPO pricing

Next Article

Traeger Inc. outlook revised to negative at S&P due to tariff exposure

Related Posts

Alibaba's Qwen Chat AI chatbot now features Deep Research

May 13, 2025  0

Under Armour forecasts quarterly sales below estimates

Under Armour forecasts quarterly sales below estimates

May 13, 2025  0

Campari posts revenues below analysts expectations, down 4%

Campari posts revenues below analysts expectations, dow...

May 8, 2025  0